United Therapeutics Corporation capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity: 0.00x
Net debt / equity: -0.18x
Debt / assets: 0.00x
Debt / EBITDA: 0.00x
Net debt / EBITDA: -0.63x

Liquidity & coverage

Current ratio: 4.79x
Quick ratio: 4.50x
Cash ratio: 3.59x
Interest coverage: 87.63x
EBITDA / interest: 104.48x
Working capital: $2.3B

Cash & dividend

FCF / debt: —
Cash flow / debt: —
Dividend per share: —
Dividend yield: —
Dividend growth 1y: —

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.